Databases Company in the public registers

VIVAX Pharmaceuticals, s.r.o.

Active

Basic details

Company ID (IČO)
36006521
Tax ID (DIČ)
2020440840
VAT ID (IČ DPH)
SK2020440840
VAT
Registered for VAT under §4 since 1/8/1996
Registered office
Moyzesova 868/67, 01701 Považská Bystrica
Legal form
Spoločnosť s ručením obmedzeným
Register entry
Obchodný register Okresného súdu Trenčín, oddiel Sro, vložka 3427/R
Employees
10-19 zamestnancov
Established
17/7/1996

Financial data

From the financial statements in the Register of Financial Statements (RÚZ), in euros, for the last 5 years (each column is one fiscal year). Not verified; shown as the company filed them.

In 2025, VIVAX Pharmaceuticals, s.r.o. decreased its revenue by 14% to €6,807,640 and its profit was €88,327. Equity rose by 4% to €1,748,236 and the debt ratio fell to 76.92%.

Revenue

VIVAX Pharmaceuticals, s.r.o.

YearRevenue
2021€10,261,617
2022€9,930,349
2023€8,235,476
2024€7,950,851
2025€6,807,640

Profit

VIVAX Pharmaceuticals, s.r.o.

YearProfit
2021€840,860
2022€196,247
2023€4,332
2024−€277,153
2025€88,327
2025
Revenue
€6,807,640
Profit
€88,327
Assets
€7,573,611
Equity and liabilities
€7,573,611
Equity
€1,748,236
Debt ratio What it shows: How much of its assets the company finances with borrowed funds.
How it is computed: (Liabilities + Accruals) / Assets
76.92%
Gross margin What it shows: The share of revenue left after the cost of goods, materials, energy and services.
How it is computed: Value added / Revenue
6.55%

Financial statements as PDF

The files open in the Register of Financial Statements (RÚZ) in a new tab.

Assets

VIVAX Pharmaceuticals, s.r.o.

As of 31/12/2025

  • €7,573,611 · 100.00%

Equity and liabilities

VIVAX Pharmaceuticals, s.r.o.

As of 31/12/2025

  • €7,573,611 · 100.00%

Total income

VIVAX Pharmaceuticals, s.r.o.

YearSales of goods, products and servicesSales of fixed assets and materialOther operating incomeInterest incomeOther financial incomeTotal
2021€10,261,617€25,163€11,761€256€34,667€10,333,464
2022€9,930,349€7,767€5,309€5,375€27,520€9,976,320
2023€8,235,476€0€10,187€95,569€25,016€8,366,248
2024€7,950,851€23,890€17,158€10,649€42,718€8,045,266
2025€6,807,640€10,486€9,434€6,704€5,223€6,839,487

Costs

VIVAX Pharmaceuticals, s.r.o.

YearCost of goods soldMaterials and energyServicesPersonnel costsDepreciationOther operating costsFinancial costsIncome taxTotal
2021€7,952,191€40,292€822,700€136,768€38,411€176,674€32,601€292,967€9,492,604
2022€8,512,703€44,840€851,940€210,183€43,061€31,966€32,707€52,673€9,780,073
2023€7,200,933€40,196€835,812€190,498€39,832€21,883€20,028€12,734€8,361,916
2024€7,092,954€44,790€833,514€214,391€69,908€54,685€6,876€5,301€8,322,419
2025€5,393,052€52,857€915,630€225,734€83,724€35,860€32,228€12,075€6,751,160

Margins

VIVAX Pharmaceuticals, s.r.o.

YearGross marginOperating marginNet margin
202114.10%11.03%8.19%
20225.25%2.50%1.98%
20231.93%−1.01%0.05%
2024−0.26%−4.00%−3.49%
20256.55%1.77%1.30%

Year-on-year change

VIVAX Pharmaceuticals, s.r.o.

YearRevenueProfit
202115%330%
2022−3%−77%
2023−17%−98%
2024−4%−6,498%
2025−14%–

Financing structure

VIVAX Pharmaceuticals, s.r.o.

YearEquityProvisionsLoans and assistanceLong-term liabilitiesShort-term liabilities
2021€2,340,847€0€3€1,013,586€6,795,394
2022€2,435,606€11,747€54€1,014,067€6,725,067
2023€1,955,574€19,169€0€1,014,394€5,607,768
2024€1,678,421€14,302€0€1,015,051€6,130,043
2025€1,748,236€14,274€23€1,092,821€4,718,257

Income tax

VIVAX Pharmaceuticals, s.r.o.

YearIncome taxCurrent tax
2021€292,967€292,967
2022€52,673€52,673
2023€12,734€12,734
2024€5,301€5,301
2025€12,075€12,075

Data sources

We take the data from the public registers as they publish it, unchanged and untranslated. FinPOST is an information website and does not verify the data. This page may be up to 7 days old. How we handle the data (privacy policy, section 3.9)